ArticleFrontiers in medicine2025
Optimization of concentration-directed blood purification therapy in the management of diquat poisoning.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diquat, a non-selective herbicide extensively used in China, is characterized by moderate toxicity and the absence of a specific antidote. Acute diquat poisoning frequently leads to multiple organ dysfunction syndrome (MODS), posing significant clinical challenges. This study investigated the application and optimization of concentration-directed blood purification therapy in patients suffering from diquat poisoning complicated by MODS. We analyzed the clinical outcomes of four patients who underwent hemodialysis, hemoperfusion (HP), and other blood purification modalities. The results demonstrated that individualized treatment regimens-guided by real-time monitoring of plasma diquat concentrations-markedly enhanced therapeutic efficacy and improved patient prognoses. By dynamically tailoring blood purification protocols to the patients' toxin levels, this study introduced a novel clinical intervention strategy for the management of acute diquat poisoning. These findings underscore the clinical value of concentration-guided blood purification therapy and offer important insights for its broader implementation in practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.